Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L3 pseudogene 9 (RPL3P9) is a processed pseudogene located on human chromosome 8 at cytogenetic region 8q21.13. It is annotated by reference databases such as NCBI Gene (ID: 100128963), HGNC (ID: 36839), and Ensembl (ENSG00000240540). As a pseudogene, RPL3P9 does not encode a functional protein and has no characterized biological activity. Pseudogenes are genomic DNA sequences derived from protein-coding genes that have lost their coding potential through mutation and typically do not produce active proteins. RPL3P9 is one of several pseudogenes related to the functional ribosomal protein L3 gene (RPL3), and is not implicated in disease, drug interaction, or recognised as a biomarker. There may be sequence similarity and limited transcriptional evidence in some datasets, but no evidence suggests it functions as a receptor, enzyme, transporter, or any other therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L3 pseudogene 9 (RPL3P9).